Drug Shortage Report for JAMP-MONTELUKAST
Report ID | 160735 |
Drug Identification Number | 02442361 |
Brand name | JAMP-MONTELUKAST |
Common or Proper name | Montelukast chewable tablets |
Company Name | JAMP PHARMA CORPORATION |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MONTELUKAST |
Strength(s) | 5MG |
Dosage form(s) | TABLET (CHEWABLE) |
Route of administration | ORAL ORAL |
Packaging size | 30 (blister pack) |
ATC code | R03DC |
ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2022-05-12 |
Estimated end date | 2023-12-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-04-12 |
Company comments | new DIN available (02514885) |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2023-04-12 | French | Compare |
v9 | 2023-04-12 | English | Compare |
v8 | 2023-03-11 | French | Compare |
v7 | 2023-03-11 | English | Compare |
v6 | 2022-10-07 | French | Compare |
v5 | 2022-10-07 | English | Compare |
v4 | 2022-07-19 | French | Compare |
v3 | 2022-07-19 | English | Compare |
v2 | 2022-05-17 | French | Compare |
v1 | 2022-05-17 | English | Compare |
Showing 1 to 10 of 10